SRNE

Sorrento Therapeutics Inc

SRNE·83587F202·US·Common Stock·Healthcare - Biotechnology

SRNE (Sorrento Therapeutics Inc) is held by 2 institutional investors as of Q2 2026. Largest holders: HUNTINGTON NATIONAL BANK ($4), First Command Advisory Services, Inc. ($0).

2
Holders
$4
Total Value
100%
Consensus
13F: Insider & Congress: Updated regularly
SRNE

Smart Money Verdict

View all
Loading verdict
Held by 2 funds

Who's Trading

Source dates: Price Aug 17, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for SRNE.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
HUNTINGTON NATIONAL BANKHUNTINGTON NATIONAL BANK
Unchanged
5,001$40.0%-99.97%
0
First Command Advisory Services, Inc.First Command Advisory Services, Inc.
New
569$00.0%-93.00%
17
SRNESRNESorrento Therapeutics Inc

Continue exploring

Smart money flow
Track where institutional capital is flowing
Discover new institutional entries
Fresh positions initiated this quarter
Check sector trends
Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYLLYELI LILLY & CO
413 holders · $667.3B
UNHUNHUNITEDHEALTH GROUP INC
413 holders · $186.4B
JNJJNJJOHNSON & JOHNSON
394 holders · $391.5B
DHRDHRDANAHER CORP
392 holders · $97.1B
ISRGISRGINTUITIVE SURGICAL INC
391 holders · $127.1B
TMOTMOTHERMO FISHER SCIENTIFIC INC
391 holders · $147.4B
BSXBSXBOSTON SCIENTIFIC CORP
389 holders · $77B
MRKMRKMERCK & CO. INC.
385 holders · $209.1B
ABBVABBVABBVIE INC
381 holders · $255.1B
ABTABTABBOTT LABORATORIES
380 holders · $129.4B
High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used